A nurse is caring for a client who has a new diagnosis of liver disease. Which of the following lab values should the nurse expect the health care provider to order to support the diagnosis?

Liver disease involves progressive hepatocellular injury resulting in impaired synthetic, metabolic, and detoxification functions of the liver. The liver is responsible for producing plasma proteins, including albumin and clotting factors. In chronic hepatic dysfunction, protein synthesis declines, leading to hypoalbuminemia, ascites, edema, and coagulopathy. Laboratory evaluation of hepatic synthetic capacity is essential in confirming severity and progression of liver impairment. Rationale: A. This option is incorrect because erythrocyte sedimentation rate is a nonspecific marker of systemic inflammation and tissue injury. It may be elevated in infections, autoimmune disorders, or malignancy but does not directly assess hepatic synthetic function. It cannot confirm liver disease severity or quantify hepatocellular dysfunction. B. This option is incorrect because C-reactive protein is an acute phase reactant produced by the liver in response to inflammation. Although it may rise in liver disease with infection or inflammation, it reflects inflammatory activity rather than hepatic synthetic failure. It is not a diagnostic marker for liver function impairment. C. This option is incorrect because D-dimer reflects fibrin degradation and is primarily used to assess thrombotic activity such as deep vein thrombosis or pulmonary embolism. While liver disease can alter coagulation pathways, D-dimer is not a direct measure of hepatic synthetic function or disease confirmation. D. This option is correct because albumin is synthesized exclusively by hepatocytes and reflects hepatic synthetic capacity. In liver disease, decreased albumin production leads to hypoalbuminemia, contributing to ascites, peripheral edema, and poor oncotic pressure. Low serum albumin is a direct indicator of chronic liver dysfunction and disease progression.